Genasys Inc. Details Board Refreshment and Executive Compensation Ahead of Annual Meeting

summarizeSummary

Genasys Inc. filed its definitive proxy statement, outlining significant board changes including the non-re-election of the Chairman and a reduction in board size, alongside new executive compensation packages for its CEO and CFO.

check_boxKey Events

• Board Composition Changes

  The board will be reduced from seven to six directors, with current Chairman Richard H. Osgood III and Mark Culhane not being re-nominated for board seats, instead transitioning to a strategic advisory committee.

• Activist Investor Influence

  R. Rimmy Malhotra, an affiliate of Nicoya Capital LLC, is nominated for re-election and is slated to serve as interim Chair of the Audit Committee if a new mutually acceptable nominee is not identified. This follows an Amended and Restated Cooperation Agreement from December 2025.

• CEO Compensation Restructuring

  CEO Richard S. Danforth's 2026 compensation includes a $490,000 base salary, a cash bonus plan (target 100% of base), and grants of 400,000 Restricted Stock Units (RSUs), replacing 800,000 previously granted performance-based options.

• CFO Compensation and Formal Appointment

  Cassandra Hernandez-Monteon was formally appointed Chief Financial Officer on December 24, 2025, with a $275,000 base salary, a bonus plan (target 50% of base), and a grant of 70,000 RSUs.

auto_awesomeAnalysis

The definitive proxy statement reveals substantial corporate governance shifts at Genasys Inc., stemming from an Amended and Restated Cooperation Agreement with Nicoya Capital LLC. The company will reduce its board from seven to six members, with the current Chairman, Richard H. Osgood III, and Mark Culhane not being nominated for re-election to the board, instead moving to a strategic advisory committee. R. Rimmy Malhotra, an affiliate of Nicoya Capital, is nominated for re-election and will serve as interim Audit Committee Chair if a new mutually acceptable nominee is not found. This indicates a significant board refreshment and increased influence from an activist investor. Additionally, the filing details new compensation structures for the CEO and CFO, including substantial RSU grants and the cancellation of prior performance-based options for the CEO, aligning executive incentives with future performance metrics.